Basic Cytotoxicity Test Assay Kit |
|||
| 969 | Immunochemistry | 125 | EUR 173 |
Crp Assay Laboratories manufactures the cfp bloods test results reagents distributed by Genprice. The Cfp Bloods Test Results reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact crp assay. Other Cfp products are available in stock. Specificity: Cfp Category: Bloods Group: Test Results
TruStrip RDT Beta-Lactam and Tetracyclines rapid test strips, results is 2-10 mins, 50 strips/pk |
||
| Alpha Diagnostics | 1 pk | Ask for price |
Peroxide assay, colorimetric micro assay kit, 96 test, Quantitative |
||
| Alpha Diagnostics | 1 kit | EUR 489.6 |
Peroxidase assay, colorimetric micro assay kit, 96 test, Quantitative |
||
| Alpha Diagnostics | 1 kit | EUR 634.8 |
TruStrip RDT Clenbuterol rapid test strips, results is 2-10 mins, 50 strips/pk |
||
| Alpha Diagnostics | 1 pk | Ask for price |
TruStrip RDT Quinolone rapid test strips, results is 2-10 mins, 50 strips/pk |
||
| Alpha Diagnostics | 1 pk | Ask for price |
TruStrip RDT Salbutamal rapid test strips, results is 2-10 mins, 50 strips/pk |
||
| Alpha Diagnostics | 1 pk | Ask for price |
TruStrip RDT Chloramphenicol rapid test strips, results is 2-10 mins, 50 strips/pk |
||
| Alpha Diagnostics | 1 pk | EUR 781.2 |
TruStrip RDT Cow/Bovine Infectious rhinitis (IBR) antibody rapid test card, results is 2-10 mins, 50 cards/pk |
|||
| RV-500300-RDT | Alpha Diagnostics | 1 pk | Ask for price |
TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk |
|||
| RV-501200-RDT | Alpha Diagnostics | 1 pk | Ask for price |
TruStrip RDT Humanized Ebola IgG (humanized IgGs expressed in tobacco or other plants) rapid test (results in 2-10 min), 25 cassettes/pk |
|||
| AE-320880-RDT-25 | Alpha Diagnostics | 1 pk | EUR 351.6 |
TruStrip RDT Human Anti-Zaire Ebola virus glycoprotein (GP) antibody rapid test (visual results in 2-10 min), 10 cassettes/pk |
|||
| AE-320625-RDT | Alpha Diagnostics | 1 pk | EUR 351.6 |
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
|||
| GEN-402-25tests | All test | 25 tests | EUR 292.8 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
|||
Multiple organs tumor tissue array, including pathology grade, TNM, clinical stage IHC markers (ER, PR, Her-2) results, 118 cases/208 cores |
|||
| BR20838 | BioCoreUSA | row: 13; column: 16; cores: 208; cases: 118 | EUR 474 |
|
Description: Multiple organs tumor tissue microarray, containing 80 cases of breast invasive carcinoma of no special type, 10 cancer adjacent breast tissue, duplicate cores per case, 4 ovary serous adenocarcinoma, 4 uterus endometrioid adenocarcinoma, 6 rectum adenocarcinoma, 6 colon adenocarcinoma, 2 esophagus squamous cell carcinoma, 2 stomach carcinoma, 2 pancreas adenocarcinoma, 2 lung carcinoma, single core per case |
|||
Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results,104 cases/208 cores |
|||
| BR20824 | BioCoreUSA | row: 13; column: 16; cores: 208; cases: 104 | EUR 474 |
|
Description: Breast tumor tissue microarray (slide 18 of 2600 cases of breast cancer survey slide set), containing 83 cases of invasive carcinoma of no special type, 4 mucinous carcinoma, 9 medullary carcinoma, 6 invasive lobular carcinoma, 1 each of apocrine carcinoma and cystosarcoma phyllodes, duplicate cores per case |
|||
Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores |
|||
| BRC051 | BioCoreUSA | row: 1; column: 5; cores: 5; cases: 5 | EUR 42 |
|
Description: Breast invasive carcinoma of no special type microarray, containing 4 casee of breast invasive carcinoma of no special type and 1 normal breast tissue, single core per case |
|||
Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores |
|||
| FMG010 | BioCoreUSA | row: 3; column: 4; cores: 10; cases: 10 | EUR 78 |
|
Description: Breast invasive carcinoma of no special type tissue microarray, containing 10 cases of breast invasive carcinoma of no special type, single cores per case |
|||
Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a |
|||
| BR1201b | BioCoreUSA | row: 10; column: 12; cores: 120; cases: 60 | EUR 354 |
|
Description: Breast carcinoma tissue microarray (most of triple negative), containing 56 cases invasive carcinoma of no special type, 2 cases invasive papillary adenocarcinoma, 1 each of medullary carcinoma and apocrine carcinoma, duplicate core per case |
|||
Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores |
|||
| BR1510 | BioCoreUSA | row: 10; column: 15; cores: 150; cases: 50 | EUR 354 |
|
Description: Breast carcinoma tissue microarray, containing 45 cases of invasive carcinoma of no special type, 2 medullary carcinoma, 1 each of metaplastic carcinoma, mixed carcinoma and apocrine carcinoma, triplicate cores per case |
|||
anti- CFP antibody |
|||
| FNab01622 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against CFP |
|||
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d |
|||
| FMG08013e | BioCoreUSA | row: 8; column: 9; cores: 72; cases: 72 | EUR 168 |
|
Description: Breast carcinoma with adjacent normal breast tissue microarray, containing 63 cases of invasive carcinoma of no special type, 6 medullary carcinoma, 3 adjacent normal breast tissue, single core per case |
|||
HBsAg Test Card (Test in Whole Blood) |
|||
| HBsAg-214 | Innovation Biotech | 4.0mm (strip in a card) 25cards/box | EUR 0.2 |
HBsAg Test Strip (Test in Whole Blood) |
|||
| HBsAg-213 | Innovation Biotech | 3.0mm (single pouch) 100pouches/box | EUR 0.1 |
Rat CFP(Properdin) ELISA Kit |
|||
| ER1467 | FN Test | 96T | EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 0.938 ng/ml |
|||
Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b |
|||
| HER2c | BioCoreUSA | row: 3; column: 4; cores: 10; cases: 10 | EUR 78 |
|
Description: Her-2 IHC Biomarker control tissue microarray of breast invasive carcinoma of no special type, containing 10 cases of invasive invasive carcinoma of no special type, single core per case |
|||